B

BeOne

Global oncology therapeutics discovery, development, manufacturing

Executive Director – Small Molecule CMC Lead

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeHopewell, VA, USAIn-person

About the Job

Requirements

  • A Ph.D. or equivalent degree in Pharmaceutical Sciences, Chemistry, Chemical Engineering, Biochemistry, or a related discipline; an advanced degree (MS/PharmD) with extensive pharmaceutical industry experience may be considered.
  • At least 8 years of pharmaceutical or biotechnology industry experience in CMC development.
  • Demonstrated experience leading CMC activities for NCE through clinical development and regulatory approval.
  • Experience supporting successful IND and NDA submissions.
  • Strong understanding of CMC development, GMP manufacturing, and regulatory CMC expectations.
  • Proven ability to lead cross-functional teams without direct authority.
  • Strong strategic thinking and problem-solving capability.
  • Ability to make data-driven decisions under uncertainty.
  • Excellent communication skills with technical, executive, and regulatory stakeholders.

Responsibilities

  • Develop and execute comprehensive CMC strategies aligned with overall development objectives and corporate goals.
  • Lead CMC planning and execution across development stages, including pivotal clinical development, registration submission, commercial manufacturing readiness, and post-approval lifecycle management.
  • Define critical CMC milestones, deliverables, timelines, resource needs, and risk mitigation strategies.
  • Provide strategic oversight of drug substance and drug product development activities, ensuring processes are scientifically sound, robust, scalable, and suitable for GMP manufacturing; partner with CDMOs and manufacturing sites to support successful clinical and commercial supply execution.
  • Ensure appropriate analytical strategies are established to support product development and regulatory requirements, and that analytical packages support regulatory submissions and lifecycle management.
  • Partner with Regulatory Affairs to develop high-quality CMC regulatory strategies and support preparation of regulatory briefing packages, responses to agency questions, and commitments.
  • Establish effective governance mechanisms for CMC decision-making and lead technical assessments and trade-off decisions balancing quality, speed, cost, regulatory expectations, and long-term commercial needs.
  • Identify CMC risks and establish mitigation plans throughout development.
  • Provide strategic oversight of CDMOs and external vendors, ensuring they deliver against agreed scope, timelines, quality standards, and budgets; lead escalation management when needed.
  • Support transition from development to commercial manufacturing, ensuring CMC readiness for PPQ campaigns, regulatory submissions and inspections, launch supply, and post-approval changes.
  • Develop lifecycle strategies to improve product robustness, cost, capacity, and supply reliability.
  • Serve as the primary CMC representative on cross-functional development teams.
  • Lead collaboration among CMC technical functions, commercial manufacturing, QA/QC, regulatory CMC, clinical development, supply chain, and external CDMO partners.
  • Ensure effective communication, alignment, and decision-making across functions.
  • Drive resolution of complex technical and operational challenges.

Desired Qualifications

  • Experience leading multiple pipeline programs simultaneously.
  • Experience managing both internal and outsourced development and manufacturing models.
  • Experience with global regulatory agencies, including FDA, EMA, and NMPA.
  • Experience with commercialization, technology transfer, PPQ, and post-approval lifecycle management.
  • Experience building CMC organizations or implementing CMC governance models.

About the Company

BeOne

Global oncology therapeutics discovery, development, manufacturing

BeOne Medicines discovers, develops, and commercializes oncology therapies worldwide, focusing on hematologic cancers and solid tumors. Its products work by leveraging internal R&D and clinical development to bring therapies to market quickly, with Brukinsa serving as a leading backbone in the US and European markets. It differentiates itself through a large-scale global clinical network and cost-efficient development and manufacturing that support high margins and a focus on large-market cancer indications. Its goal is to expand access to high-impact, affordable cancer treatments across more than 45 countries while growing its pipeline into immunology and solid tumors.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Dongcheng District, China
Founded
2010

Recently Posted Jobs

Explore more opportunities at BeOne

See more jobs